00000000星期X 00:00:00
Search
Keywords: Search scope:  
Contact Us

News

Font Size:big  middle  small

A new round of drug price cuts announced policy is expected by the end of August

Number of visits: Date:2010年11月29日 13:33
Much of the State Development and Reform Commission enterprises concerned about a new round of drug price adjustment policies, as soon as the latest developments there, the reporter recently was informed that the National Development and Reform Commission and the repercussions have been part of larger enterprises face-to-face communication, the program is expected to price cuts in 8 announced by the end. National Development and Reform Commission program because of a new round of price cuts in the industry earlier triggered strong reaction forced to postpone the announcement. However, according to reports received firm information, the State Development and Reform Commission actively brewing out of the substantive step - 7, on 19, 20, the State Development and Reform Commission Secretary departments organized a price before the proposed price cuts affected more programs the main large enterprises in Beijing Shenzhen Building a one-on-one conversation. The representative also disclosed that the final package of medicine price cut will certainly make some adjustments, from the discussion of the program, the range is limited, but his speech did not mention the last time for the publication. "Callover" form of understanding enterprise voice Top representatives who told reporters, the State Development and Reform Commission to convene this conversation did not involve all of the enterprises to participate in prices, but production cephalosporins, and other key species of the deep-seated corporate communication, these enterprises including Pfizer ,哈药, Shek medicine, Suzhou East, and others more than 20. It is learned that the State Development and Reform Commission and enterprises in the form of dialogue also innovation, is no longer a collective meeting or domestic enterprises and organizations of (foreign) funded enterprises were met, but "callover" form of one-on-one dialogue. According to this person, each individual enterprises summoned by the State Development and Reform Commission for the time half an hour to one hour from. According to report, the first to be invited to the dialogue enterprises are Pfizer, the last is the only association representatives - China Chemical Pharmaceutical Industry Association. The pharmaceutical industry on behalf of the Chinese Chemical Society to participate in this meeting is the Secretary General of the Association Zhou Yan, she confirmed to reporters in this meeting with the State Development and Reform Commission for a detailed discussion, but she refused to disclose any details of the discussion program . However, she made it clear that, from the State Development and Reform Commission attaches great importance to the views of businesses and associations, the new program than before the program will certainly be adjusted. But for the time introduction of the program, said that he could not accurately foresee. But according to the above-mentioned enterprises are disclosed to reporters, the State Development and Reform Commission has made it clear that this is the last time and Enterprise forum, I believe that the program will be submitted soon. This shows that the National Development and Reform Commission's determination to drug price cuts did not waver. China Medical Business Association Vice President Zhu Chang-ho told reporters analysis, before a government work report has explicitly pointed out that the large amount of people on drugs will carry out large-scale, substantial price cuts. Therefore, the ultimate price cuts of this magnitude there will be no great changes. For a (foreign) enterprises and domestic enterprises is the same drug has different price cut issue, Zhu Chang-hao, based on the National Development and Reform Commission consistent attitude, the domestic enterprises Wo Hop (outside) funded enterprises in the price cut also Drugs to maintain a comparatively large distance. Pricing Drugs directory pave the way for the expansion of drug price cuts In the current round of trade prices gob of the drug, July 14, the State Development and Reform Commission announced on its website on the new "National Development and Reform Commission Pricing Drugs Catalog", the scope of the government's drug pricing has been adjusted revised government pricing of medicines directory number from the original 1,500 kinds expanded to 2,400 kinds. the current round of price cuts drugs substantially "warm-up." Antibiotic production enterprises on the attitude of the wind prices Although the program has not yet final out, but prices have been rumors in the market of antibiotics set off a阵阵waves. Shandong Lu shares of pharmaceutical company marketing vice president Zhang Xiang said, but enterprises now can look forward to the early introduction of price cuts. With the emergence of price cuts hearsay, the antibiotic products were not sold on the impact of small, mostly hospitals and pharmacies stock more cautious. Hebei, a pharmaceutical enterprise sales responsible person said that the price cuts are for the pharmaceutical industry chain had a tremendous psychological impact, in the middle of commercial companies are very careful now are basically zero inventory, led directly to the current market demand antibiotics , a little depressed. Fact is not the only country affected by antibiotic production enterprises, many pharmaceutical companies are promoting new drugs to a certain extent, be pinned down. Many enterprises are reflected, to delay introduction of price cuts also affect many areas of public bidding, most of the provincial-level drugs tender has also been postponed. At present, the enterprises in the new products in order to promote the regional market, we must rush in a new round of local tender before the tender postponement also affected the enterprise's new product promotion process. Facts have proved that the previous rounds of antibiotic products prices has affected the future direction of the entire market. As for the upcoming new round of the far-reaching impact of the price cuts, Zhang Xiang believes that this price reduction involved ceftriaxone, such as cefuroxime originally belong to the high-end range of antibiotic products after the price reduction is likely This turned into low-end antibiotics. Diving prices will certainly be able to accelerate its new drug to generic drugs by the process of transformation, then the current market for the relatively large amount of cefazolin sodium, cefradine and other low-end products in the market will also have impact on the whole is likely to cause antibiotics market chain reaction.

TypeInfo: Dynamic Industry

Keywords for the information: